NasdaqGM - Nasdaq Real Time Price
USD
Braveheart Bio, Inc. (BRVE)
18.60
+1.18
(+6.80%)
At close: November 6 at 4:00:01 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
|
Purchases
|
0 | 0 |
|
Sales
|
-- | 0 |
|
Net Shares Purchased (Sold)
|
0 | 0 |
|
Total Insider Shares Held
|
47.47M | -- |
|
% Net Shares Purchased (Sold)
|
-- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | 21,377,827 |
| % Change in Institutional Shares Held | 76.29% |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LUBNER DAVID CHARLES Director |
Purchase at price 30.00 per share. | Direct | 1,666,650 | Aug 7, 2026 |
| RICKEY JAMES PAUL Chief Financial Officer |
Purchase at price 30.00 per share. | Direct | 833,310 | Aug 7, 2026 |
| CHIMOVITS EREZ Director and Beneficial Owner of more than 10% of a Class of Security |
Purchase at price 30.00 per share. | Indirect | 58,200,000 | Aug 7, 2026 |
| CHIMOVITS EREZ Director and Beneficial Owner of more than 10% of a Class of Security |
-- | Indirect | -- | Aug 7, 2026 |
| VIEHBACHER CHRISTOPHER Director |
Purchase at price 30.00 per share. | Direct | 2,499,990 | Aug 7, 2026 |
| MURDOCH TRAVIS Chief Executive Officer |
Purchase at price 30.00 per share. | Direct | 2,499,990 | Aug 7, 2026 |
| JIANGSU HENGRUI PHARMACEUTICALS CO. LTD. Beneficial Owner of more than 10% of a Class of Security |
-- | Direct | -- | Aug 7, 2026 |
